Used as a chiral building block in the synthesis of fluorinated pharmaceuticals, particularly in the development of bioactive peptides and enzyme inhibitors. Its structure allows for selective introduction of a fluorinated aromatic group with defined stereochemistry, making it valuable in medicinal chemistry for optimizing drug potency, metabolic stability, and binding specificity. Commonly employed in solid-phase peptide synthesis via Fmoc protection strategy, it enables the incorporation of a fluorinated phenylglycine derivative into target molecules. Widely applied in research settings for designing drugs targeting neurological disorders, cancer, and infectious diseases.